| # | Title | Journal | Year | Citations |
|---|
| 1 | Incidence of thrombotic complications in critically ill ICU patients with COVID-19 | Thrombosis Research | 2020 | 3,872 |
| 2 | Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy | Thrombosis Research | 2020 | 1,690 |
| 3 | Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis | Thrombosis Research | 2020 | 1,357 |
| 4 | The mechanism of action of aspirin | Thrombosis Research | 2003 | 900 |
| 5 | Growth and function of the normal human placenta | Thrombosis Research | 2004 | 704 |
| 6 | Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium | Thrombosis Research | 1977 | 673 |
| 7 | Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects | Thrombosis Research | 1980 | 644 |
| 8 | Coagulation and sepsis | Thrombosis Research | 2017 | 547 |
| 9 | Haemostatic changes in pregnancy | Thrombosis Research | 2004 | 512 |
| 10 | Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation | Thrombosis Research | 2013 | 506 |
| 11 | Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration | Thrombosis Research | 1976 | 486 |
| 12 | Evidence for a rapid inhibitor to tissue plasminogen activator in plasma | Thrombosis Research | 1983 | 474 |
| 13 | Purification of antithrombin III by affinity chromatography | Thrombosis Research | 1974 | 468 |
| 14 | Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury | Thrombosis Research | 1980 | 467 |
| 15 | Indium-111 labeled platelets: Studies on preparation and evaluation of in vitro and in vivo functions | Thrombosis Research | 1976 | 465 |
| 16 | Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis | Thrombosis Research | 2003 | 463 |
| 17 | A player of many parts: The spotlight falls on thrombin's structure | Thrombosis Research | 1993 | 456 |
| 18 | The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management | Thrombosis Research | 2020 | 454 |
| 19 | The biological significance of platelet volume: Its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration | Thrombosis Research | 1983 | 423 |
| 20 | Rat model of arterial thrombosis induced by ferric chloride | Thrombosis Research | 1990 | 416 |
| 21 | Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI) | Thrombosis Research | 1988 | 401 |
| 22 | Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH) | Thrombosis Research | 1977 | 400 |
| 23 | Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients | Thrombosis Research | 1993 | 400 |
| 24 | More to “heparin” than anticoagulation | Thrombosis Research | 1994 | 395 |
| 25 | Cell biology of tissue factor, the principal initiator of blood coagulation | Thrombosis Research | 1996 | 393 |
| 26 | Platelet physiology and thrombosis | Thrombosis Research | 2004 | 358 |
| 27 | Severe COVID-19 infection associated with endothelial activation | Thrombosis Research | 2020 | 358 |
| 28 | D-PHE-PRO-ARGCH2Cl-A selective affinity label for thrombin | Thrombosis Research | 1979 | 352 |
| 29 | The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs | Thrombosis Research | 2016 | 345 |
| 30 | An immunoassay for human D dimer using monoclonal antibodies | Thrombosis Research | 1983 | 341 |
| 31 | Heparin cofactor activity measured with an amidolytic method | Thrombosis Research | 1975 | 338 |
| 32 | The anti-inflammatory effects of heparin and related compounds | Thrombosis Research | 2008 | 336 |
| 33 | Rapid methods for isolation of human plasma fibronectin | Thrombosis Research | 1982 | 329 |
| 34 | Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil | Thrombosis Research | 1995 | 328 |
| 35 | Assay of heparin in plasma using a chromogenic substrate for activated factor X | Thrombosis Research | 1976 | 326 |
| 36 | Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody | Thrombosis Research | 1990 | 323 |
| 37 | Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin III | Thrombosis Research | 1977 | 322 |
| 38 | Chemotherapy-induced thrombosis | Thrombosis Research | 2006 | 320 |
| 39 | The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects | Thrombosis Research | 2001 | 319 |
| 40 | Effects of race and ethnicity on the incidence of venous thromboembolism | Thrombosis Research | 2009 | 319 |
| 41 | Venous thromboembolism and prognosis in cancer | Thrombosis Research | 2010 | 319 |
| 42 | The stimulation of thrombosis by hypoxia | Thrombosis Research | 2019 | 316 |
| 43 | Thrombosis risk associated with COVID-19 infection. A scoping review | Thrombosis Research | 2020 | 308 |
| 44 | Molecular Basis for the Relationship Between Thrombosis and Cancer | Thrombosis Research | 2001 | 303 |
| 45 | The release, distribution, and clearance of human β-thromboglobulin and platelet factor 4 | Thrombosis Research | 1978 | 302 |
| 46 | Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trials | Thrombosis Research | 2009 | 300 |
| 47 | Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management | Thrombosis Research | 2006 | 298 |
| 48 | The release of a human platelet specific protein measured by a radioimmunoassay | Thrombosis Research | 1975 | 294 |
| 49 | Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels | Thrombosis Research | 2020 | 292 |
| 50 | Blood Coagulation Factor XIII | Thrombosis Research | 1999 | 288 |
